REPROD BIOMED ONLINE

　　GetPortalImpactFactorByIdResponse(projectId=1,爭(zhēng)議 id=520e6299, cover=https://img.medsci.cn/images/journal/cover/2021/bUK_202109271316300260.jpg, fullname=REPRODUCTIVE BIOMEDICINE ONLINE, abbr=REPROD BIOMED ONLINE, pyear=2000, frequence=Monthly, articleNumbers=2587, citedSelf2015=9.3, acceptanceRate=50.0, submissionToAcceptance=2.75, averageReviewTime=平均2.75月, reviewFee=null, pageFee=null, publishedRatio=2023年中國(guó)人文章占該期刊總數(shù)量19.82% (2022年為20.16%), issn=1472-6483, greenSci=https://www.greensci.net/search?kw=1472-6483, scijournal=https://www.scijournal.org/impact-factor-of-REPROD-BIOMED-ONLINE.shtml, medsciHotlightString=null, medsciHotlightRealtime=6.0, medsciHotlight=6.163, medsciHotlight5year=6.85769, citescore=7.2, hIndex=111, impactFactor=4.0, orgnization=Elsevier, orgnizationUrl=http://www.elsevier.com, country=United Kingdom, countryCn=英國(guó), isOa=0, isOaString=否, sciScie=Science Citation Index Expanded|Current Contents - Clinical Medicine, bigclassCas=醫(yī)學(xué) 3區(qū), smallclassCas=醫(yī)學(xué) 3 區(qū), website=https://www.rbmojournal.com/, websiteHits=14012, guideForAuthor=https://www.elsevier.com/journals/reproductive-biomedicine-online/14726483/guide-for-authors, guideForAuthorHits=1970, submitWebsite=https://www.editorialmanager.com/rbmo/default.aspx, submitWebsiteHits=4586, content=<p>An international journal, produced on web and in paper copy, devoted to biomedical research and ethical issues surrounding human conception and the welfare of the human embryo. The period of human embryonic growth covered is between the formation of the primordial germ cells in the fetus until mid-pregnancy. High quality research on lower animals is included if it helps to clarify the human situation. Studies progressing to birth and later are published if they have a direct bearing on events in the earlier stages of pregnancy. Relevant topics include fertility and infertility, contraception, IVF and assisted reproduction, the preimplantation diagnosis of genetic disease, cloning, embryo stem cells, implantation and organogenesis, miscarriage, genetic disorders afflicting the embryo, and their alleviation, fetal operations and treatments, and the growth of embryos affected by these processes to term. Ethical and political topics arising through the treatment and care of various clinical conditions are presented. Counselling, news from wide sources, interviews with leading scientists and clinicians, replies to patients'' queries, a manufacturers'' corner, job opportunities, and other matters of relevance to the journal''s fields of study will be presented on web, paper or both. Patients will not be counselled about their condition.</p>, totalCites=10350, brief=REPROD BIOMED ONLINE雜志醫(yī)學(xué)行業(yè)，“<strong><a target="_blank" href=https://www.medsci.cn/article/"/sci/index.do?反思smallclass=婦產(chǎn)科學(xué)" >婦產(chǎn)科學(xué)</a></strong>”子行業(yè)的優(yōu)秀級(jí)雜志, articleType=論著，綜述各類型文章都接收,試管嬰兒 medsciHeat=黑紅, medsciComment=REPROD BIOMED ONLINE在該細(xì)分領(lǐng)域可能是一流雜志，可能是奇跡創(chuàng)刊時(shí)間短或不是熱門學(xué)科，整體來說，突破國(guó)內(nèi)學(xué)者關(guān)注度仍然不夠。爭(zhēng)議對(duì)于投稿而言，反思建議多向"&abbr&"投稿，試管嬰兒當(dāng)然期刊也應(yīng)該加強(qiáng)品牌宣傳。奇跡,突破 medsciExplanation=MedSci期刊指數(shù)是根據(jù)中國(guó)科研工作者（含醫(yī)學(xué)臨床，基礎(chǔ)，爭(zhēng)議生物，反思化學(xué)等學(xué)科）對(duì)SCI雜志的認(rèn)知度，熟悉程度，以及投稿的量等眾多指標(biāo)綜合評(píng)定而成。當(dāng)然，具體的，您還可以結(jié)合“<a href=https://www.medsci.cn/article/'https://www.medsci.cn/sci/submit.do?id=520e6299'>投稿經(jīng)驗(yàn)系統(tǒng)</a>”，進(jìn)行綜合判斷，這更是大家的實(shí)戰(zhàn)經(jīng)驗(yàn)，值得分享和參考。<br>

　　注意，上述MedSci期刊指數(shù)采用MedSci專利技術(shù)，由計(jì)算機(jī)系統(tǒng)自動(dòng)計(jì)算，并給出建議，存在不準(zhǔn)確的可能，僅供您投稿選擇雜志時(shí)參考。, tags=[ImpactFactorTagDto(id=12144, tagName=輔助生殖, createdHits=1), ImpactFactorTagDto(id=65815, tagName=PGS, createdHits=1), ImpactFactorTagDto(id=65816, tagName=線粒體拷貝數(shù), createdHits=1), ImpactFactorTagDto(id=202, tagName=胚胎, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2017, citescore=2.65), GetImpactFactorCiteScoreListResponse(year=2018, citescore=2.84), GetImpactFactorCiteScoreListResponse(year=2019, citescore=4.6), GetImpactFactorCiteScoreListResponse(year=2020, citescore=5.1), GetImpactFactorCiteScoreListResponse(year=2023, citescore=7.2)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=6.631), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=6.806), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=6.806), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=6.218), GetImpactFactorMedsciIndexListResponse(year=2025, medsciHotlight=6.0)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Obstetrics and Gynecology , rank=21/166), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Reproductive Medicine , rank=12/63), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Developmental Biology , rank=27/76)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1472-6483[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=REPRODUCTIVE BIOMEDICINE ONLINE[ta], article_number=253, article_number_cn=51, isJournalMember=null, journalType=sci)